Sonnet BioTherapeutics has received a patent from the European Patent Office (EPO) for its fully human albumin binding (F H ...

Monoclonal antibodies have specificity for a particular antigen (target of antibodies), but polyclonal ones are not specific to any antigen. Recombinant ones are monoclonal, and here are the key ...

Blinatumomab is a bispecific T cell engager (BiTE) antibody construct to treat adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukaemia (ALL).

This study uncovers a unique broad neutralization mechanism against rotavirus, where antibody 7H13 destabilizes the partial structure of the viral VP4 spike by acting on a critical residue switch ...

European Patent Office (EPO) grants EU Patent No. EP3583125 B1 covering the Company’s Fully Human Albumin Binding (FHAB®) ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...